Tuesday, September 16, 2014 5:30:06 PM
So many medicines fail on poor metabolic stability resulting in failed phase trial testing. Would bet that is why AVINIR was able to bring forth something no one ever thought of...
This leaves Concert in the drivers seat for so so many things. Baker Bros knew to buy them early and you can bet the will go in and get a huge offering at some point...
They are making money, although not enough... The AVP-786 is only the begining for these guys...
I was scepticle until this last trial by AVNR... Now we know... Imagine making a pain reliever that last 3 times longer... What is that worth...OMG !
FEATURED Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market • Mar 18, 2024 8:51 AM
FEATURED Prospera Energy Inc. Announces a 508% increase in the 2023 Proven Developed Producing (PDP) Reserve Valuation • Mar 18, 2024 8:09 AM
HealthLynked Corp Announces Chris Hall as New Chief Technology Officer • HLYK • Mar 19, 2024 8:00 AM
Greenlite Ventures Enters into Strategic Alliance with Woodway USA • GRNL • Mar 15, 2024 4:00 PM
HealthLynked Welcomes David Rosal as New Chief Financial Officer • HLYK • Mar 13, 2024 8:00 AM
ECGI Holdings, Inc. Announces Continued Efforts in Financial Optimization • ECGI • Mar 13, 2024 8:00 AM